ID   TIG-3
AC   CVCL_E939
SY   TIG3; Tig3; Tokyo Institute of Gerontology-3
DR   BTO; BTO:0006282
DR   Cell_Model_Passport; SIDM01886
DR   ChEMBL-Cells; CHEMBL4295477
DR   ChEMBL-Targets; CHEMBL4296501
DR   PRIDE; PXD000523
DR   PRIDE; PXD001068
DR   PRIDE; PXD001499
DR   PubChem_Cell_line; CVCL_E939
DR   RCB; RCB4468
DR   Wikidata; Q54972457
RX   PubMed=7053395;
RX   PubMed=9548301;
RX   PubMed=15900046;
WW   http://proteome.tmig.or.jp/2D/Fibro/humfb_menu.html
CC   Population: Japanese.
CC   Senescence: Senesces at 83.8 PDL (PubMed=7053395).
CC   Doubling time: 18-24 hours (PubMed=7053395).
CC   Omics: Deep proteome analysis.
CC   Omics: Proteome analysis by 2D-DE.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3210 ! TIG-3S
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 18
//
RX   PubMed=7053395; DOI=10.1093/geronj/37.1.33;
RA   Matsuo M., Kaji K., Utakoji T., Hosoda K.;
RT   "Ploidy of human embryonic fibroblasts during in vitro aging.";
RL   J. Gerontol. 37:33-37(1982).
//
RX   PubMed=9548301; DOI=10.1002/elps.1150190232;
RA   Toda T., Kaji K., Kimura N.;
RT   "TMIG-2DPAGE: a new concept of two-dimensional gel protein database
RT   for research on aging.";
RL   Electrophoresis 19:344-348(1998).
//
RX   PubMed=15900046; DOI=10.1093/jnci/dji133;
RA   Mashima T., Oh-hara T., Sato S., Mochizuki M., Sugimoto Y.,
RA   Yamazaki K., Hamada J.-i., Tada M., Moriuchi T., Ishikawa Y., Kato Y.,
RA   Tomoda H., Yamori T., Tsuruo T.;
RT   "p53-defective tumors with a functional apoptosome-mediated pathway: a
RT   new therapeutic target.";
RL   J. Natl. Cancer Inst. 97:765-777(2005).
//